IMA Clinical Research St. Petersburg — St. Petersburg, Florida

IMA Clinical Research St. Petersburg is a clinical research site located in St. Petersburg, Florida, United States 33704.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

IMA Clinical Research St. Petersburg has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Obesity, Overweight, Chronic Low Back Pain (CLBP).

Sponsors: Eli Lilly and Company, Boehringer Ingelheim, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IMA Clinical Research St. Petersburg?

IMA Clinical Research St. Petersburg has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IMA Clinical Research St. Petersburg conducted?

IMA Clinical Research St. Petersburg has 5 clinical trials on record, with 5 currently active. Their work covers Obesity, Overweight, Chronic Low Back Pain (CLBP).

Is IMA Clinical Research St. Petersburg accredited by Crixeo Health?

IMA Clinical Research St. Petersburg has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IMA Clinical Research St. Petersburg?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.